Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome® system 11G/8G vs. ATEC® system 12G/9G

Order, B.; Schaefer, Philipp J.; Peters,; Eckmann-Scholz, Christel; Hilpert, Felix; Strauß, Alexander; Warneke, Viktoria; Mathiak, Micaela; Heller, Martin; Jonat, W.; Schaefer, Fritz

doi:10.1258/ar.2012.120420

Cited by 6 publications

(4 citation statements)

References 18 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The present study showed that the occurrence of hematoma was 11.4% (39/343). This result was similar to that reported by Vargas et al (8) but less than that reported by some previous studies (6,9).…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions

et al. 2020

View full text Add to dashboard Cite

Background: The exact factors and mechanisms involved in the development of hematoma after breast ultrasound (US)-guided vacuum-assisted biopsy (VAB) are not clear. This study aimed to analyze the occurrence, prognosis, and risk factors of hematoma after US-guided VAB for the removal of benign breast lesions. Methods: This was a retrospective study of consecutive female patients with breast lesions (BI-RADS 3/4a/4b and confirmed as benign by core needle biopsy) removed by percutaneous excisional biopsy by USguided VAB at the Beijing Chaoyang Hospital from April 2016 to December 2018. Univariable analyses were conducted to identify the factors associated with hematoma (age, nodule size, laterality, nodule location, number of nodules, BI-RADS classification of ultrasound, pathology, breast shape, menstrual period, efficacy time of bandage, and hemostatic agents). Multivariable analysis was performed to identify the factors independently associated with hematoma.Results: A total of 293 patients (343 breast lesions) were included. Lesion removal was successful in all cases. Hematomas ≥1 cm were found in 39 patients. Finally, 38 (97.4%) hematomas were absorbed completely within 6 months. The multivariable logistic regression analysis revealed that lesion size (P<0.001;

show abstract

Section: Discussionsupporting

confidence: 91%

“…The size of the specimen was about (0.3-0.5 cm) × (1.8-2.0 cm) for each sample. The mean number of samples obtained from a single insertion was 10 (range, [5][6][7][8][9][10][11][12][13][14][15][16][17][18]. The procedure lasted 10-30 min.…”

Section: Us-guided Excisional Vabmentioning

confidence: 99%

Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions

et al. 2020

View full text Add to dashboard Cite

show abstract

“…VACB proves to be a method that eliminates or to a large extent limits these disadvantages [11]. It is an efficient, minimally invasive, relatively inexpensive procedure with a good cosmetic effect, and has a low complication rate [12]. Similar to minimally invasive techniques used in the treatment of other organs, VACB, in some cases, can be an alternative to a more extended surgical procedure [13].…”

Section: Discussionmentioning

confidence: 99%

Clinicopathological Factors Associated with Remnant or Regrowth of Benign Breast Tumor after Previous Vacuum-Assisted Core Biopsy

2017

View full text Add to dashboard Cite

Purpose: We sometimes encounter remnant or regrowth of benign breast tumors diagnosed as Breast Imaging-Reporting and Data System (BI-RADS) C4 in follow-up breast ultrasound after previous vacuum-assisted core biopsy (VACB). We aimed to evaluate the factors that influence remnant or regrowth tumors at post-VACB site or adjacent tissue. Methods: From January 2010 to December 2015, we analyzed 647 cases on follow-up. Patients were divided into two groups; group A was defined as patients without recurrent masses on breast ultrasonography during the follow-up period, and group B was defined as those with recurrent masses diagnosed as more than BI-RADS C4 on ultrasonography. Results: Fibrocystic changes, proliferative disease without atypia, intraductal papilloma, apocrine cell change, atypical ductal hyperplasia, sclerosing adenosis, and radial scars were observed in 89.5% (n= 579), 15.9% (n= 103), 15.3% (n= 99), 5.3% (n= 34), 5.7% (n= 37), 7.6% (n= 49), and 6.3% (n= 41) of patients, respectively. During the follow-up period, 85 patients were diagnosed as group B. Group B was significantly associated with proliferative diseases without atypia, sclerosing adenosis, and microcalcifications compared to group A (p= 0.008, p= 0.007, and p= 0.001, respectively). After adjustment for confounding variables, group B was more significantly associated with proliferative breast diseases than group A (hazard ratio [HR], 0.558; 95% confidence interval [CI], 0.343-0.907; p= 0.018). Furthermore, group B was more significantly associated with intraductal papilloma (HR, 0.571; 95% CI, 0.342-0.953; p= 0.032). Conclusion: Previously diagnosed proliferative diseases without atypia or microcalcification at first VACB were significantly associated with recurrent breast tumor. Intraductal papilloma was also significantly associated with tumor regrowth.

show abstract

“…The preserved architecture also facilitates easier interpretation on histopathology examination, avoiding the crushing and fragmentation artefacts seen in fragmented tissue cores. 20 A review of the current literature, however, shows that no studies have been made to compare the accuracy between fragmented cores and en-bloc specimens. Further studies are warranted to establish any possible improvements in diagnosis.…”

Section: Quality Of Specimensmentioning

confidence: 99%

Ultrasound-guided Percutaneous Radiofrequency-assisted Breast Excision to Remove En-bloc Specimens: Five Years' Experience

Tee¹,

Lui²,

Lau³

et al. 2014

Hong Kong J Radiol

View full text Add to dashboard Cite

Objectives: To describe our initial 5-year experience in using the radiofrequency-assisted excision technology in a regional hospital, with an emphasis on the efficacy, techniques, and safety of the procedure. Methods: Clinical records and operative data of all patients who underwent ultrasound-guided radiofrequencyassisted excision of breast lesions between September 2008 and May 2013 in Kwong Wah Hospital, Hong Kong, were retrospectively reviewed. Results: A total of 48 consecutive patients and 50 lesions with a mean diameter of 9.2 mm were included. Of the 50 lesions, 27 (54%) were graded Breast Imaging-Reporting and Data System (BI-RADS) 3, 21 (42%) BI-RADS 4, and 2 (4%) BI-RADS 5. The mean operating duration was 6.3 minutes. Final pathology showed 1 ductal carcinoma in-situ, 20 fibroadenomata, 11 fibrocystic changes, 9 papillomata, and 11 miscellaneous benign entities. Complete removal with histological clear margins was achieved in 82% of the lesions. No histological underestimation or recurrence was found on subsequent open surgery or follow-up. The procedure was welltolerated, with a mean pain score of 1.35 out of 5. One patient (2%) experienced a complication of haematoma formation requiring surgical treatment. Conclusion: Ultrasound-guided percutaneous radiofrequency-assisted breast excision is a robust diagnostic tool and therapeutic procedure that allows safe, quick, and efficacious en-bloc lesion removal with clear margins. This minimally invasive office procedure is a promising alternative to conventional open excision of benign breast lesions.

show abstract

Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome^® system 11G/8G vs. ATEC^® system 12G/9G

Cited by 6 publications

References 18 publications

Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions

Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions

Clinicopathological Factors Associated with Remnant or Regrowth of Benign Breast Tumor after Previous Vacuum-Assisted Core Biopsy

Ultrasound-guided Percutaneous Radiofrequency-assisted Breast Excision to Remove En-bloc Specimens: Five Years' Experience

Contact Info

Product

Resources

About